Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Cotellic
| Field | Information |
|---|---|
| Medication Name | Cotellic |
| Generic Name | Cobimetinib |
| Boxed/Label Warning | May cause new primary malignancies, serious skin toxicities, hemorrhage, cardiomyopathy, retinal pigment epithelial detachments, and embryo-fetal toxicity. |
| Purpose | Used in combination with vemurafenib to treat melanoma that has spread to other parts of the body or cannot be removed by surgery, and has a certain type of abnormal BRAF gene. |
| Mechanism of Action | A kinase inhibitor that targets MEK (MAPK/ERK kinase), a protein kinase involved in cell growth. It helps slow down or stop the growth of cancer cells. |
| Dosage Forms | Oral tablets |
| Available Strengths | 20 mg |
| Dosage Frequency | Typically once daily for 21 days followed by a 7-day rest period, as part of a 28-day cycle. |
| Common Side Effects | Diarrhea, nausea, vomiting, fatigue, rash, photosensitivity, liver enzyme elevations, muscle pain, swelling. |
| Serious Side Effects | New primary malignancies, serious skin toxicities (Stevens-Johnson syndrome, toxic epidermal necrolysis), hemorrhage, cardiomyopathy (decreased heart function), retinal pigment epithelial detachments, embryo-fetal toxicity, venous thromboembolism. |
| Drug Interactions | Strong CYP3A inhibitors (e.g., ketoconazole), strong CYP3A inducers (e.g., rifampin), drugs that prolong the QT interval. |
| Important Notes | Must be used in combination with vemurafenib. Use effective contraception during treatment and for at least 2 weeks after the last dose. Report any new skin lesions or changes in vision to your doctor immediately. Avoid prolonged sun exposure. |
| Storage | Store at room temperature away from moisture and light. |
| Missed Dose | If a dose is missed by more than 12 hours, skip the dose and take the next dose at the regular time. Do not double the dose. |
| Alternatives | Zelboraf (vemurafenib) – often used in combination with Cotellic, Tafinlar (dabrafenib), Mekinist (trametinib). Selumetinib, Binimetinib. |
Cotellic Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Zelboraf (vemurafenib) | BRAF kinase inhibitor | Used in combination with Cotellic for BRAF V600 mutation-positive melanoma. |
| Tafinlar (dabrafenib) | BRAF kinase inhibitor | Alternative BRAF inhibitor, often used in combination with a MEK inhibitor. |
| Mekinist (trametinib) | MEK inhibitor | A MEK inhibitor that can be used in combination with a BRAF inhibitor in certain melanoma cases. |
| Selumetinib | MEK inhibitor | Used to treat neurofibromatosis type 1 (NF1) in pediatric patients. |
| Binimetinib | MEK inhibitor | Can be used in combination with encorafenib. |
Cotellic Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Diarrhea | New primary malignancies |
| Nausea | Serious skin toxicities (Stevens-Johnson syndrome, toxic epidermal necrolysis) |
| Vomiting | Hemorrhage |
| Fatigue | Cardiomyopathy (decreased heart function) |
| Rash | Retinal pigment epithelial detachments (vision problems) |
| Photosensitivity | Embryo-fetal toxicity |
| Muscle pain | Venous thromboembolism (blood clots) |
| Swelling (edema) | Liver enzyme elevations |
Cotellic Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Metastatic Melanoma (with BRAF V600 mutation) | 60 mg (three 20 mg tablets) | 60 mg once daily for 21 days, followed by a 7-day rest period (28-day cycle) | Administer in combination with vemurafenib. Take at the same time each day. Do not crush or chew tablets. |
Cotellic Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $2,500 – $10,000 |
| Without Insurance (U.S.) | $20,000 |
| From CPS | $9,454.99 |
